The company was founded on May 18, 1992. On April 26, 1993, the company was listed on the Shenzhen Stock Exchange with the approval of the National Sports Reform Commission Document No. 87 (1992) and Su Zhengfu (1992) Document No. 62 of the Jiangsu Provincial People's Government. The company is mainly engaged in biomedical products, production and sales, and landscaping engineering business. The company's main products include EPO injections, injectable interleukin-2, etc.
相关临床试验
0
0 进行中
药物批准
4
批准总数
监管机构
1
监管机构数
成立时间
1992
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无资讯文章